BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28553897)

  • 1. Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis.
    Cariou E; Bennani Smires Y; Victor G; Robin G; Ribes D; Pascal P; Petermann A; Fournier P; Faguer S; Roncalli J; Rousseau H; Chauveau D; Carrié D; Berry I; Galinier M; Lairez O;
    Amyloid; 2017 Jun; 24(2):101-109. PubMed ID: 28553897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
    Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
    Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy.
    Liu D; Hu K; Niemann M; Herrmann S; Cikes M; Störk S; Gaudron PD; Knop S; Ertl G; Bijnens B; Weidemann F
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):1066-72. PubMed ID: 24100046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac amyloidosis screening using a relative apical sparing pattern in patients with left ventricular hypertrophy.
    Nakao Y; Saito M; Inoue K; Higaki R; Yokomoto Y; Ogimoto A; Suzuki M; Kawakami H; Hiasa G; Okayama H; Ikeda S; Yamaguchi O
    Cardiovasc Ultrasound; 2021 Aug; 19(1):30. PubMed ID: 34425846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy.
    Arenja N; Fritz T; Andre F; Riffel JH; Aus dem Siepen F; Ochs M; Paffhausen J; Hegenbart U; Schönland S; Müller-Hennessen M; Giannitsis E; Kristen AV; Katus HA; Friedrich MG; Buss SJ
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1414-1422. PubMed ID: 28165128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
    Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
    Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
    Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
    Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
    Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
    Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease.
    Namdar M; Steffel J; Jetzer S; Schmied C; Hürlimann D; Camici GG; Bayrak F; Ricciardi D; Rao JY; de Asmundis C; Chierchia GB; Sarkozy A; Lüscher TF; Jenni R; Duru F; Brugada P
    Am J Cardiol; 2012 Feb; 109(4):587-93. PubMed ID: 22105784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Electrocardiogram Is a Poor Diagnostic Tool to Detect Left Ventricular Hypertrophy in Children: A Comparison with Echocardiographic Assessment of Left Ventricular Mass.
    Bratincsák A; Williams M; Kimata C; Perry JC
    Congenit Heart Dis; 2015; 10(4):E164-71. PubMed ID: 25600360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.
    Phelan D; Collier P; Thavendiranathan P; Popović ZB; Hanna M; Plana JC; Marwick TH; Thomas JD
    Heart; 2012 Oct; 98(19):1442-8. PubMed ID: 22865865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon.
    Cappelli F; Gallini C; Costanzo EN; Tutino F; Ciaccio A; Vaggelli L; Bartolini S; Morini S; Martone R; Angelotti P; Frusconi S; Di Mario C; Perfetto F
    Int J Cardiol; 2018 Mar; 254():346-350. PubMed ID: 29407121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging.
    Krittayaphong R; Nomsawadi V; Muenkaew M; Miniphan M; Yindeengam A; Udompunturak S
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S124-32. PubMed ID: 23590032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
    Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
    Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic left ventricular hypertrophy has low diagnostic accuracy in middle-aged subjects.
    Vottonen P; Husso M; Sipola P; Vanninen R; Peuhkurinen K; Magga J
    Blood Press; 2007; 16(5):328-34. PubMed ID: 17852087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.